Scientists reported that targeting β1 integrin (β1I) significantly improved radium 223 outcome and points towards combinatorial application in prostate cancer tumors with high β1I expression.
[Journal of Nuclear Medicine]
Sorry, but the selected Zotpress account can't be found.
